SCHEMBL5810083

SCHEMBL5810083

CCOC(=O)c1cc(C)nc2ccc(Br)cc12

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.79
ALDH1A1 P00352 4/20 0.78
SMN1; SMN2 Q16637 2/20 0.78
KDM4E B2RXH2 9/20 0.65
GAA P10253 3/20 0.65
L3MBTL1 Q9Y468 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP1A2 P05177 1/20 0.54
TSHR P16473 1/20 0.54
MAPK1 P28482 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
MAPT P10636 2/20 0.53
GABRA1 P14867 1/20 0.51
GABRB1 P18505 1/20 0.51
GABRA3 P34903 1/20 0.51
GABRB2 P47870 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25217075 0.88 ALDH1A1 (1.00) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL30758183 0.86 L3MBTL1 (0.72) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL24951547 0.83 TSHR (0.61) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL11669167 0.82 ALDH1A1 (0.71) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL31133520 0.81 KDM4E (0.72) ALDH1A1KDM4EGAAL3MBTL1HPGD
SCHEMBL5810312 0.81 KDM4E (0.72) ALDH1A1KDM4EGAAL3MBTL1HPGD
SCHEMBL24619210 0.81 ALDH1A1 (0.69) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL7365268 0.81 ALDH1A1 (0.66) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL2000832 0.81 SMN1; SMN2 (0.62) ATMALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL31510551 0.81 ALDH1A1 (0.66) ATMALDH1A1SMN1; SMN2KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116745291-A N- (2- (4-cyanothiazolidin-3-yl) -2-oxoethyl) -quinoline-4-carboxamide 阿斯利康(瑞典)有限公司 2023-09-12 CN disclosed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed